The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...
Oxford Medical Products has revealed positive topline results from the first randomised controlled trial (RCT) of Sirona, its innovative, non-invasive and non-pharmaceutical weight loss technology.
GLP-1 drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by around half. Meanwhile, tech companies are ...
Oxford Medical Products has revealed positive topline results from the first randomised controlled trial (RCT) of Sirona, its innovative, non-invasive and non-pharmaceutical weight loss technology.